Focused strategy for Africa with distribution capabilities in key African economies (21Countries).
Ability to grow in a highly volatile emerging market.
Innovative and goal driven Healthcare company (Pharma, Disposables, Devices and Ortho):
Over 9,000 products
25 years of experience
35 regulatory pharmacists
9 health care production facilities
US$160 million annual turnover
Accessing high value dossiers (Proprietary IP) from across the globe building and sustaining long term partnerships
Type of organisation: Development Finance Institution (DFI)
Ownership: 100% owned by South African Government
Total assets: USD 9.6 billion (31 March 2017 – group)
Total liabilities: USD 3.1 billion (31 March 2017 – group)
Funding status: Fund operations and growth from investments, pay dividends & income tax
Credit rating: Baa3 (Moody’s)
Main business area: Providing funding for big business, entrepreneurs and projects contributing to industrialization
Geographic activities: South Africa and the rest of Africa
Stage of investment: Project identification and development, feasibility, commercialization, expansion, modernization
No. of employees: 839 (March 2017)
Operational footprint: Head Office in Johannesburg & 20 Regional and Satellite offices
MembersChairperson: Mr Mehmet Levent Selamoglu (Turkey).
Non-Executive Directors: Dr Vikramkumar Naik, Dr Tadesse Teferi Mekonen (Ethiopian), Dr Ntuthuko Melusi Bhengu, Dr Vathiswa Belinda Papu-Zamxaka,
Mr Shawn Renders, Mr Andrè Meyer.
Executive Directors: Prof Aletta Petronella Susarah Terblanche (Managing Director, Ex-Officio Member of the Board); and Dr Caryn Janine Fenner (Alternate Director).
Company Secretary: Felicity Ranthako